Dr. Marcella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
277 George St
New Brunswick, NJ 08901Phone+1 732-235-6700- Is this information wrong?
Education & Training
- Bridgeport Hospital/Yale UniversityResidency, Pediatrics, 1984 - 1987
- Albany Medical CenterInternship, Internal Medicine, 1983 - 1984
- New York University School of MedicineClass of 1983
Certifications & Licensure
- NJ State Medical License 1995 - 2025
- PA State Medical License 1987 - 1996
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- 6 citationsBezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.Anirban Basu, Vimalanand S. Prabhu, Mary Beth Dorr, Yoav Golan, Erik R. Dubberke, Oliver A. Cornely, Sebastian M. Heimann, Alison Pedley, Ruifeng Xu, Mary E. Hanson, S...> ;Open Forum Infectious Diseases. 2018 Nov 1
- 17 citationsThirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.Vimalanand S. Prabhu, Oliver A. Cornely, Yoav Golan, Erik R. Dubberke, Sebastian M. Heimann, Mary E. Hanson, Jane Liao, Alison Pedley, Mary Beth Dorr, Stephen Marcella> ;Clinical Infectious Diseases. 2017 Oct 1
- 8 citationsPosaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effe...Thomas S. Y. Chan, Stephen Marcella, Harinder Gill, Yu-Yan Hwang, Yok-Lam Kwong> ;Journal of Medical Economics. 2016 Jan 1
- Join now to see all
Journal Articles
- Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab with Antibacterial Drug Treatment for Clostridium Difficile InfectionStephen Marcella, Yoav Golan, Clinical Infectious Diseases
Press Mentions
- Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRABOctober 23rd, 2022
- Shionogi to Present in Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (Cefiderocol) Against Gram-Negative PathogensSeptember 29th, 2021
- Significant Costs Linked to Hospital-Acquired C. DifficileJuly 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: